April 14 (Reuters) - Edwards Lifesciences Corp EW.N:
EDWARDS SAPIEN M3 RECEIVES CE MARK, BECOMING WORLD’S FIRST TRANSFEMORAL TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.